This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Post Holdings, Inc.
5/9/2025
Welcome to the Post Holdings Second Quarter 2025 Earnings Conference Call and Webcast. At this time, all participants have been placed on a listen-only mode, and the floor will be open for your questions following the presentation. If you would like to ask a question at that time, please press star 1 on your telephone keypad. If at any point your question has been answered, you may remove yourself from the queue by pressing star 2. So others can hear your questions clearly, we ask that you pick up your handset for best sound quality. Lastly, if you should require operator assistance, please press star zero. I would now like to turn the call over to Daniel O'Rourke, Investor Relations for Post.
Good morning. Thank you for joining us today for Post's second quarter fiscal 2025 earnings call. I'm joined this morning by Rob Vitale, our President and CEO, Jeff Zadix, our COO, and Matt Maynor, our CFO and Treasurer. Rob, Jeff, and Matt will make prepared remarks, and afterwards, we'll answer your questions. The press release that supports these remarks is posted on both the investors and the SEC filings portions of our website, and is also available on the SEC's website. As a reminder, this call is being recorded, and an audio replay will be available on our website at postmovings.com. Before we continue, I would like to remind you that this call will contain forward-looking statements. which are subject to risks and uncertainties that should be carefully considered by investors as actual results could differ materially from these statements. These forward-looking statements are current as of the date of this call and management undertakes no obligation to update these statements. This call will discuss certain non-GAAP measures. For a reconciliation of these non-GAAP measures to the nearest GAAP measure, see our press release issued yesterday and posted on our website. With that, I will turn the call over to Rob.
Thank you, Daniel. Good morning, all. I'm going to make some thematic comments, and Jeff and Matt will take you through the order. First, we performed well in a difficult environment. I expect that to continue. Second, trade policy and regulations continue to grab headlines. We will manage those as they develop. Third, consumer sentiment is weak. We expect we will need to focus on demand drivers and flawless supply chain execution. First and last, uncertainty in the capital markets complicates M&A valuations. With that, I will turn the call over to Jeff and Matt, who will take you through the quarter. Jeff?
Thanks, Rob, and good morning, everyone. Given the volatile macro backdrop and challenges associated with avian influenza, We are especially pleased with our Q2 results. Our puts team did a fantastic job navigating incredibly difficult egg markets as they prioritize customer supply while at the same time mitigating some of the expected net cost impacts. Meanwhile, our retail businesses offset volume pressures with cost control and supply chain execution. As a reminder, last quarter we guided that Q2 would be down $30 to $50 million compared to Q1 as a result of avian influenza costs ahead of pricing impacts in food service. Actual Q2 food service adjusted EBITDA was approximately $20 million lower than Q1, as $30 million of costs ahead of pricing impact was partially offset by manufacturing and supply chain performance improvements. Setting aside the temporary impact of avian influenza, underlying business trends versus last year remain encouraging despite a backdrop of poor food service foot traffic. Our selling proposition continues to prove out as our mix of higher value-added egg products grew once again. Looking to the balance of the fiscal year, additional avian influenza pricing became effective starting in April, and our flock repopulation is on track. Assuming no additional outbreaks in our network, We expect to balance our egg sourcing and demand by Q4, and we continue to expect we will recover the unfavorable costs ahead of pricing impact we saw in Q2 during the remainder of fiscal 25. Moving on to post-consumer brands, we had a solid quarter while navigating volume declines in both grocery and pet. In grocery, our cost structure continued to benefit from last September's plant closure. However, the cereal category declines accelerated to down 3.7%, with our branded portfolio slightly behind at down 4.5%. Category declines continue to pressure our manufacturing utilization and cost structure, which drove our recent decision to close two more plants by the end of the calendar year. Our pet volume consumption was down 4.5% versus a flat category as we continue to face declines in nutrition demand and distribution and gravy train price elasticities. we were able to offset these lower PEP volumes with improved supply chain and SG&A cost performance. Finally, our relaunch of the Nutrish brand is currently hitting the shelves, and while it is very early, the first reactions are encouraging. Turning to refrigerated retail, Q2 adjusted EBITDA was down versus prior year primarily because of Easter timing, which fell during Q2 a year ago. In addition, similar to our food service business, we experienced costs ahead of pricing in eggs, with pricing taking effect in April, which will benefit Q3. Our focus continues to be on driving volumes in our side business, driving lower costs, and integrating our newly acquired PPI business. At Weedabix, performance improved after our ERP conversion last quarter. While we still limited promotional activities in Q2, we saw yellow box consumption relatively in line with the category, which was down 1.5%. We expect to improve margins in the back half of the year through sequential volume growth as we ramp up marketing with targeted activations and further execute our cost-out initiatives. Before turning the call over to Matt, a couple of comments on M&A and capital allocation. The recent tariff actions and volatility in capital markets have slowed what was an active M&A pipeline for us. The uncertainty in this environment points to smaller tactical transactions, such as our recent acquisition of PPI, or transactions where we have clear line of sight to synergies. With that said, we have continued to lean into share repurchases and have now bought approximately 6% of the company since the beginning of the fiscal year. From both a leverage and a liquidity position, we remain very well positioned for opportunistic capital allocation. With that, I'll turn the call over to Matt.
Thanks, Jeff, and good morning, everyone. Second quarter consolidated net sales were $2 billion, and adjusted EBITDA was $347 million. Sales decreased 2% as lower overall volumes in our retail businesses were partially offset by elevated avian influenza-driven pricing in food service and volume growth in shakes. Turning to our segments, post-consumer brands' net sales decreased 7%, driven by lower volumes in both cereal and pet. Cereal volumes decreased 6%, primarily due to category dynamics. Pet volumes decreased 5% as we continue to lap reductions in lower margin business and gravy train pricing elasticities, along with lower consumption, particularly in Nutrish. As expected, these pressures were partially offset by customer inventory recovery from deloading last quarter due to our TSA cutover. Segment-adjusted EBITDA increased 2% versus prior year as we benefited from improved cost performance for both grocery and pet. Food service nut sales increased 10% and volumes increased 3%. Revenue reflects elevated avian influenza-driven pricing and higher shake sales. Excluding shakes, volumes were down by 1% driven by HPAI dynamics impacting eggs and lower customer foot traffic impacting both eggs and potatoes. Adjusted EBITDA decreased 6% driven by avian influenza costs ahead of pricing, partially offset by improved manufacturing and supply chain performance. Refrigerated retail nut sales decreased 7% and volumes decreased 5%. Volumes across all products were affected by the timing of Easter, which was in Q2 last year. Egg volumes were impacted further by limited availability due to avian influenza. Segment adjusted EBITDA decreased 14% driven primarily by lower volumes and costs ahead of pricing in eggs and sows. Weedabix net sales decreased 5% versus the prior year. Foreign currency represented a headwind of 70 basis points. Volumes decreased 7% driven by lower promotions due to our Q1 ERP conversion, non-core product discontinuations and elasticities related to pricing decisions, which we will lap later in the fiscal year. Segment-adjusted EBITDA increased 9% versus prior year, led by increased net pricing from our prior year profit-enhancing decisions, partially offset by increased input costs and lower volumes from promotional blackouts. Turning to cash flow, we generated $160 million from operations and approximately $70 million in free cash flow, net upcap expense. This was a decrease sequentially from last quarter, which is primarily due to working capital timing. Year-to-date, free cash flow was $240 million. From a capital allocation standpoint, we favored share repurchases as we repurchased 1.7 million shares at an average price of approximately $110 per share. In addition, we spent $124 million to acquire PPI. The net effect of our capital allocation versus free cash flow this quarter increased our net leverage slightly to 4.5 times. With our earnings released last night, we increased our adjusted EBITDA guidance range to $1.43 billion to $1.47 billion. While we plan to recover Q2 food service costs ahead of pricing in the second half, we expect this to be largely offset by lower performance in PCB from continued elevated cereal category volume declines and anticipate disruption in nutrition as we fully ramp its relaunch. Thank you for joining us today, and I will now turn the call back over to the operator.
The floor is now open for questions. At this time, if you have a question or comment, please press star 1 on your telephone keypad. If at any point your question is answered, you may remove yourself from the queue by pressing star 2. Again, we ask that you pick up your handset when posing your questions to provide optimal sound quality. Thank you. Our first question is coming from Andrew Lazar with Barclays. Please go ahead.
Andrew Lazar So much good morning. I know POST has already raised several times its view on the structural run rate it expects from the food service unit, and looks as though the underlying segment, again, sort of excluding the cost ahead of pricing piece, was, again, above that level. Is the long-term run rate here now even higher than you thought previously, or are there other reasons why maybe it came in so much better than we and some others had modeled this quarter?
Yeah. Go ahead. Andrew, I think it's hard to completely parse out avian influenza, but I think your comment that, hey, does that indicate 126 relative to the 105 we've talked about in the past? I think in reality it's somewhere between those two numbers, but we need a couple quarters of normalcy, get the avian influenza behind us and back in balance in terms of our supply and demand, and then we can make a better call on what that run rate is, but clearly higher than 105.
Okay, thanks for that. And then, you know, in the quarter, it looks like you were able to maintain pretty solid margins in PCB despite the volume declines you saw in Ready to Eat and Pet. I guess, would your expectation be that the recent announcements you made around the incremental, you know, asset optimization moves in serial should allow you to maintain strong profitability in this segment going forward, even if sort of serial category volume trends remain, you know, as challenged as what we saw this past quarter? Thanks so much.
So, Andrew, clearly that's the objective is to do our best to manage our costs to maintain the profitability. If we're seeing 4% or 5% year-on-year declines, that's going to be challenging. Our expectation would be, in the medium term at least, that that would start to temper and that we would get back to 1% to 2% down, probably not in the second half of this year, but longer term. So if we can get the category to more of that historic decline, we think that those actions would enable us to maintain our margins along with the normal cost-out activities that we would do on a regular basis.
Great. Thanks so much.
Thank you.
Thank you. And your next question comes from the line of David Palmer with Evercore ISI. Please go ahead.
Yeah, thanks. So just building on that line of questioning from Andrew, I'm thinking about PCB for fiscal 26 and how you're generally thinking about the setup there. You know, clearly you have the plant closures and the tailwinds continuing there. And then the big two with PET and cereal. And I can imagine that cereal might be a back-weighted situation or one that just slowly gets better in your thinking. And maybe that's offset by maybe some of the things that you've been talking about, the drags ending and the co-man agreements and the improvements in nutrition. Maybe you'd be thinking about that pet business perhaps offsetting cereal next year. So, rough strokes, how are you thinking about your businesses within PCB and your ability to have at least a little bit of EBITDA growth from PCB next year? Thanks.
I think you laid it out exactly how we're thinking about it. This year has been a transition year for PET, so we had to get off the TSA with Smucker. We had to do some of the heavy lifting on the brand relaunch for Nutrish, and obviously we expect that those activities will bear some fruit into next year and would enable us to offset some of the headwinds that we're seeing in the cereal business. At the same time, we're going to do what we can on the cereal side to manage our costs, look to innovation and renovation to drive some volume, even if the category continues to be challenged. So the combination of those things, we think, will enable us to mitigate the headwinds we're seeing to the best of our ability. Thank you.
Thank you. And our next question comes from the line of Ken Goldman with JP Morgan. Please go ahead.
Hi, thank you. On PCB, the price mix downturn this quarter, I'm just wondering if you could elaborate a little bit on the key drivers there and how we might think about that line item ahead for the rest of the year.
Yeah, I think as I talked about second half PCB down over first half, it's going to offset some of the pricing recovery we have in food service. And our expectation in the near term is the category remains where it's at for the balance of the fiscal year, which will put some pressure on cereal year over year for sure. Again, we've seen in terms of a mixed standpoint this past quarter, we saw customers shift to larger pack sizes, which hurts mixed a little bit. I think for right now, we're kind of holding firm to what we saw in Q2 for the balance of the year.
All right, thank you for that. And then just as we get closer to the debt maturities for 8th Avenue, do you have any updated thoughts on the potential optionality of that business and maybe Post's potential role within that?
Well, we have a lot of confidence in the business operations itself. Obviously, we have to resolve the near-term maturities, and we will have a resolution one way or the other fairly soon.
Okay, thank you.
Thank you. And our next question comes from the line of Michael Lavery with Piper Sandler. Please go ahead.
Thank you. Good morning.
Good morning.
Just was looking to get a little better sense of how to think about some of the savings from the cereal plant closures you just announced. And we can get a little bit of an idea of the timing, just that it's the end of the calendar year. Are there potential offsets or, you know, any maybe magnitude you can give or just how to think about the impact from that?
Yeah, I think we called out about a $20 million annualized benefit from the plant closures as that calendar year. So you would get three-quarters of that next fiscal year. I think, you know, if the category slows down to a more normalized down 1% to 2%, you know, that's going to be in line with what we're seeing on the volume decline impact versus the cost savings of the plant shutdown. I think the challenge is that the category doesn't slow down. Then we've got some more optimization to do, and we have some more leverage we can pull.
And I guess maybe specifically was trying to get at how much that's net or gross relative to things like operating deleverage or, you know, just the the loss volume piece, is that just the gross piece from the facility savings or does it kind of bundle it all together?
That would be the gross savings. So to the extent that there's incremental deleveraging beyond that, that would be an offset.
Yeah, and to be fair, we are in the early stages of our planning for FY26, so we don't want to run our plan and exploded until we're ready.
No, fair enough. And just on the pet piece of the business, if you have a consumer that's getting more cautious, I know you have a few brands positioned differently, but how much can you characterize the benefit from trade down? Would that generally be a net positive? How do you think about just the impact from those share moves if you get a more stretched or cautious consumer overall?
Yeah, there's a meaningful shift down that would tend to favor us because a large number of our brands tend to be on the value side of the equation. We do have some brands that play in the more premium side as well, but we tend to be up and down the value chain with a skew towards the lower price point products, particularly in dry dog foods.
And would it be fair to characterize it similar to serial where obviously you could lose some share on the branded side but more than make up for it with what you gain on the low end?
Well, that depends on a lot of variables. I mean, clearly in serial we have a much higher percentage of the low end of the value chain given our position in private label as well as bagged serial. Our position in PET on the low end is not nearly the same market share that we have in cereal.
Fair enough. That's a great color. Thanks.
Thank you. And our next question comes from the line of John Baumgartner with Mizuho Securities. Please go ahead.
Good morning. Thanks for the question. I wanted to come back to refrigerated retail and the Bob Evans, the side dishes. I think expansion opportunities have been one of the aspirations there over the years. And we've seen some innovation here and there and some emphasis and de-emphasis on different segments. And I think in general, we've seen some encouraging volume signs at retail in the last couple of quarters. I'm wondering if you could speak at this point to what you're seeing in the category expectations for distribution expansion over the next 12 months. in terms of what your supply chain allows, returns on recent efforts and innovation, just kind of broader thoughts on expectations for retail going forward. Thank you.
Yeah, so clearly the PPI acquisition gives us capacity to do a number of things that maybe we couldn't have done before. We've also improved our capacity through internal improvements in our own plants that we've owned even prior to the PPI acquisition. You've been with us a long time, so you remember the years when we had to stop preparing certain products because we couldn't meet customer demand. Those days are behind us, so now we can play more offense than we have in the past. What we're seeing in the category is there's a trade down that's occurring with private label which is a phenomenon that has not been an issue in that category years ago. What we saw years ago was that private label really didn't have the quality, and it would come in and out, but it never really stuck. This time around, we're seeing that private label has better quality, and it's taking some demand away from products like ours. with the new capacity that we have available, it enables us to think about how we look at other categories. Does it make sense to play in private label? Does it make sense to play up and down the value chain while continuing to maintain our significant market share in the Bob Evans brand? In terms of innovation or renovation in that brand, We put a lot of that on hold given the issues that we had through COVID and even prior to COVID with our capacity utilization. Now with the availability of capacity, we can begin to do more of that, which we would expect to do in the latter half of this year and into next year.
Okay, thanks for that. And then to come back to PCB and some of the serial category headwinds, I think you had seen this about a decade ago where birth rates were down, you had some shipped to substitute products. Back then it was frozen breakfast in restaurants. Now you could argue it's you know, more protein shakes. So the macro headwinds, we've seen these cycles before. And I'm curious, if you put that to the side, do you see anything else fundamentally having changed, whether it's, you know, post-inflation price points for the category, whether it's a broader shift, you know, towards protein that's stickier this time around? I guess, is there anything in the environment that's maybe more structurally changed that would sort of, you know, change how you grow the category, your aspirations for the category, your ability to kind of, you know, circle the wagons on the value price point.
Any thoughts there? That would include GLP-1s in that. So there's certainly some impact on GLP-1s in the demand. And I think there will be some lapping that has to occur in the next, you know, six to 18 months. So that's the one difference in the next, you know, in the prior 10 months. We didn't have.
Okay. Okay. Thanks, Rob. Thanks, Jeff.
Thank you. And once again, if you do have a question, you may press star 1 on your telephone keypad at this time. And your next question comes from the line of Scott Marks with Jefferies. Please go ahead.
Hey, morning, guys. Thanks for taking our questions. First thing I wanted to ask about is we've heard from some of your competitors recently, notably in serial, about more so increasing promotional activity to drive value for consumers. And I don't think I heard that mentioned kind of in your prepared remarks, you know, more so around innovation and renovation. So just wondering if you can share any color on your thoughts into kind of the trade spend piece.
So our view of the category cereal we're talking about is that promotional activities are at what we would call normal levels. Certainly you go through ebbs and flows in a given year or a given time period within a year where one producer might be promoting more and others not and vice versa in subsequent periods. So we haven't seen anything that we would consider to be – you know, out of the ordinary for any significant stretch of time. Our personal approach is to continue to do the types of programs that drive value. So we have seen that promotion for promotion's sake does not generate the return in volume that you give up in price. So you have to find the sweet spot that works for your products and works for your profitability. And that's the plan that we have now and going forward.
Got it. And then last one from me. I know it's still early in the acquisition of PDI, but just wondering if you can share any color on initial learnings or insights that you have from that and how you plan on leveraging that. Thanks.
Yeah, it is early. I think the thing I would say is that There are some synergies that we probably didn't realize are there that in the longer or medium to long term that will be there. Probably the other learning is that the initial integration or acquisition, we had some upset in our employee population there that was probably a little bit more significant than we thought going in. So the ramp up that we're going to see is going to be slower than perhaps we initially expected, but it's going to fit well into our network. It's going to provide us opportunities, like I mentioned before, to think about that category in a different way compared to the way we've had to think about it based on some constraints we've had before we acquired it.
Understood. Thanks so much.
Thank you. And your next question comes from the line of Mark Tarenti with Wells Fargo. Please go ahead.
Hey, good morning, and thank you for the questions. I guess just first, grocery in general, category volumes remain under pressure. A lot of that's consumer pressure that we're seeing out there. But thinking more in terms of relative performance, who are you seeing outperforming? Is it more value in private label? Is it smaller players? And then since quarter end, have you seen any sequential improvement in any of your category trends?
So the first part of your question, I think it's a real dichotomy. There's take cereal category as an example. You see some of the more premium organic natural marketed as healthier for you but fairly expensive, not fairly, really expensive price points doing well in the category while the overall category is not performing well. So I think what we're seeing in consumers is there's a pocket of consumers that are spending for what they perceive as better for them and are willing to pay essentially whatever necessary to get that type of product. And then you've got other consumers who are cutting back significantly and de-loading their pantries and buying less frequently, which is affecting the expandable demand that we see in more normal times with cereal where people have products in their pantry and they tend to eat it when it's available. What we're seeing is that they're just de-loading their pantries because they don't have the money to go and restock. And then I'm sorry, I zoned out on the second part of your question.
Yeah, just any sequential improvement since quarter end in any of your categories?
Yeah, it's not great improvement, but the worst months for cereal were February and March. A little bit of improvement in April, but we're clearly not ready to claim victory in that regard.
Okay, and then just an update on the RTD shake manufacturing ramp. Shakes were called out as the driver of positive food service volumes. Did you make better progress during the quarter than you expected, and is your outlook for the contribution there still consistent with prior? Thanks.
Keep in mind that the baseline comparison was essentially zero for shakes. So compared to last year, any production would have been an improvement. We are seeing improvement sequentially. It's slower than what we would like it to be, but it is trending in a favorable direction. But it is still not a material contributor to profit at the current levels. So we would expect continued ramp up, again, maybe a little bit slower than we had hoped when we communicated this six, nine months ago. But in the long run, we still see the same finish line in terms of where that profitability can take us.
Thank you. And your next question comes from the line of Carla Casella with JPMorgan. Please go ahead.
Hi, thank you. One follow-up on Ken's question about 8th Avenue. What are the options there, and is there a scenario where you buy in and reconsolidate that business?
Well, I think I would start with recalling that we wrote this to Xero two or three years ago. With that, we consider it like a new investment opportunity with which we have a great deal of prayer, experience, and knowledge. Beyond that, I'm not going to comment on all the various iterations of opportunities that could exist for the company.
Okay. Great. Thank you.
Thank you. This concludes today's Post Holdings Second Quarter 2025 Earnings Conference Call and Webcast. Please disconnect your line at this time and have a wonderful day.